These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
125 related articles for article (PubMed ID: 14057524)
21. [PATHOGENESIS OF THE BASIC SYMPTOMS OF PARKINSONISM DUE TO BIOCHEMICAL CHANGES IN THE SUBCORTICAL AND STEM STRUCTURES OF THE EXTRAPYRAMIDAL SYSTEM]. TRAVENEC I Cas Lek Cesk; 1964 Jun; 103():748-52. PubMed ID: 14180121 [No Abstract] [Full Text] [Related]
22. [PATHOGENESIS OF THE BASIC SYMPTOMS OF PARKINSONISM DUE TO BIOCHEMICAL CHANGES IN THE SUBCORTICAL AND STEM STRUCTURES OF THE EXTRAPYRAMIDAL SYSTEM]. TRAVENED I Cas Lek Cesk; 1964 Jun; 103():748-52. PubMed ID: 14178689 [No Abstract] [Full Text] [Related]
23. [DETECTION OF ASYMPTOMATIC FORMS OF HEPATO-LENTICULAR DEGENERATION]. CAMBIER J Presse Med (1893); 1963 Sep; 71():1775. PubMed ID: 14091588 [No Abstract] [Full Text] [Related]
24. [HEPATOCEREBRAL OR HEPATOLENTICULAR DEGENERATION]. AKSOY M; BIYAL F; SECER F; CAKIRGOEZ C; CETINGIL AI Tip Fak Mecm; 1964; 27():37-55. PubMed ID: 14140395 [No Abstract] [Full Text] [Related]
25. Extrapyramidal and cerebellar movement disorder in association with heterozygous ceruloplasmin gene mutation. Kuhn J; Miyajima H; Takahashi Y; Kunath B; Hartmann-Klosterkoetter U; Cooper-Mahkorn D; Schaefer M; Bewermeyer H J Neurol; 2005 Jan; 252(1):111-3. PubMed ID: 15654567 [No Abstract] [Full Text] [Related]
27. [Ceruloplasmin in hepatolenticular degeneration and the effect of copper on oxidative activity of ceruloplasmin]. Wald I; Galewicz A; Górska D Neurol Neurochir Pol; 1971; 5(5):622-9. PubMed ID: 4258660 [No Abstract] [Full Text] [Related]
29. FILTERABLE AND NON-FILTERABLE SERUM COPPER. (2). STUDIES WITH 64CU. OSBORN SB; WALSHE JM Clin Sci; 1964 Apr; 26():213-7. PubMed ID: 14161054 [No Abstract] [Full Text] [Related]
30. Further investigations on ceruloplasmin in hepatolenticular degeneration and on the effect of copper on oxidase activity of ceruloplasmin. Wald I; Galewicz A; Górska D Pol Med J; 1972; 11(3):733-9. PubMed ID: 5047986 [No Abstract] [Full Text] [Related]
31. Copper metabolism after living donor liver transplantation for hepatic failure of Wilson's disease from a gene mutated donor. Kobayashi S; Ochiai T; Hori S; Suzuki T; Shimizu T; Gunji Y; Shimada H; Yamamoto S; Ogawa A; Kohno Y; Sunaga M; Shimazu M; Tanaka K Hepatogastroenterology; 2001; 48(41):1259-61. PubMed ID: 11677941 [TBL] [Abstract][Full Text] [Related]
32. Metabolic aspects of Wilson's disease: a review. SIMPSON JF Med Bull (Ann Arbor); 1963; 29():145-54. PubMed ID: 13977562 [No Abstract] [Full Text] [Related]
33. Copper and ceruloplasmin metabolism in the LEC rat, an animal model for Wilson disease. Kodama H; Murata Y; Mochizuki D; Abe T J Inherit Metab Dis; 1998 Jun; 21(3):203-6. PubMed ID: 9686357 [No Abstract] [Full Text] [Related]
34. [IMPORTANCE OF CHROMATOGRAPHIC ANALYSIS OF THE URINE FOR THE DIAGNOSIS OF CONGENITAL METABOLISM DISORDERS]. ORT M; KUCERA J; JANSA M Cesk Pediatr; 1964 Mar; 19():204-10. PubMed ID: 14142696 [No Abstract] [Full Text] [Related]
36. [Copper, ceruloplasmin and the pathogenesis of hepatolenticular degeneration]. Chromý K Cas Lek Cesk; 1965 Oct; 104(43):1173-7. PubMed ID: 5322100 [No Abstract] [Full Text] [Related]